SeerSEER -4.05%53 FCF Yield % is -54.65 as of Jun. 26, 2026. GuruFocus rates SEER with a GF Score™ of 53/100 and a GF Value™ of $2.19 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,418 Biotechnology companies, Seer ranks worse than 83.43% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Seer's Trailing 12-Month Free Cash Flow is $-49.88 Mil, and Market Cap is $91.82 Mil. Therefore, Seer's FCF Yield % for today is -54.65%.
The historical rank and industry rank for Seer's FCF Yield % or its related term are showing as below:
SEER'
s FCF Yield % Range Over the Past 10 Years
Min: -76.72 Med: -37.32 Max: -1.51
Current: -54.65
During the past 8 years, the highest FCF Yield % of Seer was -1.51%. The lowest was -76.72%. And the median was -37.32%.
SEER's FCF Yield % is ranked worse than 83.43% of 1418
companies
in the Biotechnology industry
Industry Median: -9.715
vs SEER: -54.65
Seer's FCF Margin % for the quarter that ended in Mar. 2026 was -580.38%.
Seer FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Seer FCF Yield % Related Terms
Seer FCF Yield % Historical Data
* Premium members only.
The historical data trend for Seer's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Seer's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seer FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Seer's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Seer's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seer (SEER) has a FCF Yield % of -54.65 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Seer and its competitors. According to the industry distribution chart, Seer ranks #1183 out of 1418 companies in the Biotechnology industry, placing it in the top 83.4%.
Is Seer's FCF Yield % too high?
Seer's current FCF Yield % is -54.65. Based on the distribution chart, Seer ranks #1183 out of 1418 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Seer has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Seer's FCF Yield % compare to PEPG and ALDX?
According to the Biotechnology industry distribution chart, Seer ranks #1183 out of 1418 companies for FCF Yield %. This places Seer in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Seer and its competitors. Seer's current FCF Yield % is -54.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seer stock overvalued right now?
Based on GuruFocus' analysis, Seer (SEER) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.19, compared to a current price of $1.67 — trading 23.7% below its estimated fair value. The current FCF Yield % is -54.65. Seer's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Seer (SEER), the current FCF Yield % is -54.65 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Seer (SEER) Overvalued in 2026?
Based on GuruFocus' analysis, Seer stock appears to be undervalued.
The current stock price of $1.67 is trading 23.7% below its estimated GF Value™ of $2.19.
GuruFocus considers Seer to be Modestly Undervalued.
Key valuation signals for SEER:
FCF Yield %: -54.65
GF Value™: $2.19 vs. price of $1.67 (23.7% below fair value)
No single metric tells the full story. See the SEER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
53GF Score
Get the complete analysis for SEER
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SEER has been successfully added to your 
